NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

新型神經調節技術為精神衛生保健提供了增長機會

Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care

出版商 Frost & Sullivan 商品編碼 987566
出版日期 內容資訊 英文 47 Pages
商品交期: 最快1-2個工作天內
價格
新型神經調節技術為精神衛生保健提供了增長機會 Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care
出版日期: 2020年12月24日內容資訊: 英文 47 Pages
簡介

使用藥物和心理療法治療精神疾病受到與治療相關的副作用的局限性,並且無法獲得有效的緩解。結果,神經調節技術已被用來處理這些狀況。

然而,這些傳統的神經調節療法具有諸如侵入性特徵和與治療相關的併發症等缺點,可以使患者有效地緩解精神疾病,同時又不存在這種精神調節,因此需要開發新的神經調節劑,具有侵入性,安全性和耐受性。

本報告探討了新的神經調節技術,並提供了有關增長機會,創新,專利,融資和競爭以及主要公司的信息。

目錄

第1章執行摘要

  • 調查範圍
  • 調查方法

第2章行業概述

  • 全世界精神健康疾病的負擔增加
  • 神經調節技術解決了治療精神疾病的藥物和心理治療方法的局限性
  • 傳統神經調節方法的缺點阻礙了其廣泛採用
  • 新的神經調節療法的技術細分
  • 經顱電刺激可對大腦特定皮質區域進行神經調節
  • 經顱磁刺激可促進大腦寬而深的皮層下結構的神經調節
  • 通過顱電療法刺激對大腦皮質和皮質下區域進行神經調節的能力
  • 迷走神經,枕骨和三叉神經調節可治療精神疾病
  • 應用分析:通過擴大應用範圍為開發新的神經調節技術的公司提供有利的增長機會
  • 專欄基準
  • TMS的影響相對較大(與其他新的神經調節技術相比)

第3章活躍公司

  • 經顱直流電刺激系統,用於治療抑鬱症
  • 其他用於治療抑鬱症的經顱直流電刺激系統
  • 經顱磁刺激系統,用於治療抑鬱症和強迫症
  • 其他用於治療抑鬱症的經顱磁刺激系統
  • 耳罩式顱腦電刺激儀,用於治療焦慮症,抑鬱症和失眠症
  • 其他治療焦慮和抑鬱症的著名顱電療法刺激系統
  • 外部三叉神經刺激系統,用於治療患者的注意缺陷/多動障礙
  • 其他用於治療精神疾病的非侵入性迷走神經刺激和多通道腦神經調節系統

第4章融資和聯盟評估

  • 國立衛生研究院(NIH)對新興神經調節技術的資助分析
  • 新的神經調節技術的融資評估
  • 精神保健公司與醫療保健提供者之間的合作關係,以改善獲得神經調節療法的機會
  • 精神健康神經調節參與者收購以改善知識產權和產品組合

第5章增長機會和專利分析

  • 增長機會:技術創新(2020年)
  • 增長機會1:可穿戴式神經調節療法促進遠程健康
  • 增長機會2:將AI整合到神經調節系統中以提供智能治療
  • 增長機會3:無創神經調節療法公司與專業心理健康提供者之間的合作關係,以改善服務欠佳的人群
  • 專利方案:經顱磁刺激系統的主要專利
  • 專利方案:經顱電刺激和三叉神經刺激系統的主要專利

第6章主要聯繫信息

第7章後續步驟

  • 下一步
  • 為什麼會結霜,為什麼現在會結霜?
  • 免責聲明
目錄
Product Code: D9D8

Breakthrough Innovations in Transcranial Electrical Stimulation, Transcranial Magnetic Stimulation, Cranial Electrotherapy Stimulation and other Non-invasive Neuromodulation Therapies Bolstering the Psychiatric Toolbox

The treatment of mental health disorders using pharmaceuticals and psychotherapy are plagued with limitations such as therapy-related adverse effects, and inability to provide effective remission. This has driven the use of neuromodulation techniques for managing these conditions. However, these traditional neuromodulation therapies have their share of drawbacks including invasive profile and therapy-related complications, that have necessitated the development of novel neuromodulation methods that can provide effective relief from mental disorders for the patients, while at the same time are non-invasive, safe, and tolerable.

This growth opportunity-technology (GO-TE) report highlights the innovations in non-invasive neuromodulation technologies being implemented for treating mental health conditions, including transcranial electrical stimulation, transcranial magnetic stimulation, cranial electrotherapy stimulation and other therapies such as transcutaneous vagus nerve stimulation, trigeminal nerve stimulation, and multi-channel simultaneous stimulation.The scope of this GO-TE is global. This GO-TE studies some of the path breaking innovators in this space and their technology readiness levels. The report also discusses the funding, partnerships, and emerging growth opportunities.

Table of Contents

1.0:Executive Summary

  • 1.1 Scope of the Research
  • 1.2 Research Methodology
  • 1.2 Research Methodology (continued)

2.0:Industry Overview

  • 2.1 Growing Burden of Mental Health Disorders Globally
  • 2.2 Neuromodulation Techniques Address the Limitations of Drug-based and Psychotherapy Methods for Managing Mental Disorders
  • 2.3 Drawbacks of Traditional Neuromodulation Methods are Hindering their Wide-spread Adoption
  • 2.4 Technology Segmentation for Emerging Neuromodulation Therapies
  • 2.5 Transcranial Electrical Stimulation Enabling Neuromodulation of Specific Cortical Regions of the Brain
  • 2.6 Transcranial Magnetic Stimulation Facilitates Neuromodulation of Wide and Deeper Subcortical Structures in the Brain
  • 2.7 Enabling Neuromodulation of Cortical and Subcortical Areas in the Brain through Cranial Electrotherapy Stimulation
  • 2.8 Neuromodulation of Vagus, Occipital, and Trigeminal Nerve for Treating Mental Disorders
  • 2.9 Application Analysis: Increasing Application Areas Offer Lucrative Growth Opportunities for Companies Developing Emerging Neuromodulation Technologies
  • 2.10 Benchmarking Rubrics
  • 2.11 Impact of TMS to be Relatively High as Compared to Other Emerging Neuromodulation Technologies

3.0 Companies to Action

  • 3.1 Transcranial Direct Current Stimulation System for Managing Depression
  • 3.2 Other Notable Transcranial Direct Current Stimulation Systems for Treating Depression
  • 3.3 Transcranial Magnetic Stimulation System for Managing Depression and Obsessive-compulsive Disorder
  • 3.4 Other Notable Transcranial Magnetic Stimulation Systems for Depression Treatment
  • 3.5 Over-ear Headphone-based Cranial Electrotherapy Stimulator Device for the Treatment of Anxiety, Depression, and Insomnia
  • 3.6 Other Notable Cranial Electrotherapy Stimulation Systems for Treating Anxiety and Depression
  • 3.7 External Trigeminal Nerve Stimulation System for Treating Attention-deficit/Hyperactivity Disorder in Patients
  • 3.8 Other Notable Non-invasive Vagus Nerve Stimulation and Multi-channel Brain Neuromodulation Systems for Managing Mental Disorders

4.0 Funding and Partnerships Assessment

  • 4.1 Analysis of National Institutes of Health (NIH) Funding for Emerging Neuromodulation Technologies
  • 4.2 Funding Assessment for Emerging Neuromodulation Technologies
  • 4.3 Partnerships between Mental Health Companies and Health Providers for Improving Access to Neuromodulation Therapies
  • 4.4 Acquisitions by Mental Health Neuromodulation Participants for Improving Intellectual Property and Product Portfolio

5.0 Growth Opportunities and Patent Analysis

  • 5.1 Growth Opportunity: Emerging Neuromodulation Technology Innovations, 2020
  • 5.2 Growth Opportunity 1: Distance Health Facilitated through Wearable-enabled Neuromodulation Therapies
  • 5.3 Growth Opportunity 2: Incorporating Artificial Intelligence into Neuromodulation Systems for Providing Smart Therapy
  • 5.4 Growth Opportunity 3: Partnerships between Non-invasive Neuromodulation Therapy Companies and Specialized Mental Health Providers to Improve Access to Underserved Populations
  • 5.5 Patent Scenario-Key Patents for Transcranial Magnetic Stimulation Systems
  • 5.6 Patent Scenario-Key Patents for Transcranial Electrical Stimulation and Trigeminal Nerve Stimulation Systems

6.0: Key Contacts

  • 6.1 Key Contacts

7.0 Next Steps

  • 7.1 Your Next Steps
  • 7.2 Why Frost, Why Now?
  • Legal Disclaimer